the gene regulatory networks (GRNs) of C/T types in human and mouse that we reconstructed from thousands of publicly available gene expression profiles. It takes as input gene expression data from cell fate engineering experiments, and produces three outputs ( Fig. 1) : (i) a classification score indicating the extent to which a query sample is indistinguishable in its expression profile from each of the reference C/T types; (ii) a metric of the extent to which a cell-or tissue-specific GRN is established in a query sample (GRN status); and (iii) a list of transcription factors scored according to the probability that their expression modulation would improve the desired fate change, which we refer to as the network influence score (NIS).
By applying CellNet to gene expression data of compatible cell engineering experiments in the public domain, we answered several lingering and pressing questions in the field. First, we found that cells derived by directed differentiation resembled their in vivo target cell types more closely than those derived through direct conversion. Second, we found that the GRNs of the starting cell type frequently are maintained in cells engineered through either direct conversion or directed differentiation. Third, we documented the substantial improvement of target cell-type GRN status when cell fate engineering was practiced in situ, or after engineered cells were transplanted into their native niche. Finally, we discovered the aberrant establishment of GRNs of other cell types (neither the starting nor the target) in engineered cells, an insight that led to the discovery of a colon/liver bipotent endoderm progenitor resulting from direct conversion of fibroblasts toward a hepatocyte fate 9 .
CellNet has been applied in diverse cell engineering contexts, including improved engineering of hepatocytes [10] [11] [12] , direct conversion of fibroblasts to cardiomyocytes 13 , the characterization of the maturation of engineered cardiomyocytes 14 , the functional improvement of directly converted macrophages 9 , and the detection of a multilineage primed state in engineered hematopoietic stem cells 15 .
The original version of CellNet was applied to microarray data 8 . On the basis of the recent widespread accessibility of RNA-seq as a method for estimating gene expression, we additionally demonstrate here the use of CellNet to analyze RNA-seq data. To increase the accessibility of CellNet and its reproducible use, we have created an 'image' on Amazon's EC2 cloud, on which we have installed all the software and R packages needed to follow this protocol. We have also provided example training and query data sets, as well as intermediate results for each step in the PROCEDURE, so that the user can test each step. We note that the user will be charged for any costs associated with using Amazon Web Services (AWS).
Applications of the method
CellNet was designed primarily as a tool to aid in cell fate engineering, and most applications to date have been in this context. However, CellNet can be applied in any biological context in which it would be informative to assess the status of tissuespecific and cell-type-specific GRNs and cell-type identity. For example, one could use CellNet to predict the tissue of origin for metastatic cancers for which the primary tumor is unknown 16 . More generally, CellNet could be applied to expression data of tumors to explore how normal GRNs are rewired by tumorigenesis, and, even more broadly, to explore how normal C/T regulatory networks are affected by other diseases or chronic states. In the future, we will extend CellNet to single-cell RNA-seq. We have not yet assessed the ability of CellNet to estimate the relative contribution of C/Ts to populations of mixed composition.
Comparison with other methods
Traditionally, the molecular profiles of engineered populations have been compared with the starting and target C/T types using unsupervised approaches such as principal component analysis or hierarchical clustering (HCL). We have shown that classification by HCL has lower precision as compared with CellNet classification 8 . More importantly, by incorporating the GRNs of many C/T types, CellNet can detect the aberrant activation of alternative C/T GRNs (i.e., those that are associated with neither the starting nor the target C/T type). Several new approaches to assess and/or suggest improvements to cell fate engineering protocols have been described, which we recently reviewed 17 . ScoreCard assesses the lineage propensity of nominally pluripotent populations 4 , and PluriTest assesses the resemblance of such populations to embryonic stem cells 18 . TeratoScore compares profiles of teratomas with those of mature cell types as a quantitative readout on the teratoma assay of pluripotency 19 , and KeyGenes compares profiles of engineered populations with those of fetal tissues 20 . There are several computational approaches that can be used to suggest improvements to cell fate engineering. Only a few of these approaches have been prospectively tested, including Mogrify 21 , which also uses GRNs to prioritize sets of transcription factors, and the approach of D'Alessio et al. 22 , which scores fate-defining factors based on specificity of expression.
Limitations of the protocol
There are several limitations to the current protocol. The first limitation is that we require strict adherence to our preprocessing pipeline, which consists of trimming reads and applying the RNA-seq quantification tool, Salmon, to estimate expression, so that query expression profiles can be meaningfully compared with the training data. Second, the protocol is limited to those cell and tissue types that are publicly available as raw data. We have trained CellNet platforms based on RNA-seq data from 16 human and 16 mouse C/T types, and we will continue to add more types as sufficient data become available. Finally, although a common goal in cell fate engineering is the derivation of a relatively homogeneous population of a single cell type, this version of CellNet is trained on data from bulk populations or tissues, rather than data from single cells.
Level of expertise needed to implement the protocol
The step-by-step protocol and supporting information within this document are designed for intermediate to advanced users of the R programming language. Preprocessing raw RNA-seq data requires the use of command-line tools such as Salmon and cutadapt. Therefore, experience using the shell and installing programs from source code is highly recommended.
Experimental design
The PROCEDURE describes how to use CellNet to analyze RNAseq query data and how to construct CellNet (Fig. 2) . The steps listed here assume that the user is performing the analysis on Amazon's cloud service EC2 using the Amazon machine image (AMI), the training data, and the query data that we have provided. Users must adjust some of the code to adapt the protocol to their own data (e.g., file names and R function call arguments).
If users wish to analyze query data and are not adding to or creating a new CellNet platform, then they should follow only Steps 1-12. We illustrate these parts of the PROCEDURE by analyzing a published time course of reprogramming to pluripotency using a doxycycline-inducible system in murine cells 23 and the directed differentiation of human induced PSCs (iPSCs) to hippocampal dentate gyrus granule neurons 24 . We have provided FASTQ files, a metadata table, and preprocessed query data so that the user can walk through all these steps. For users to adapt the protocol for their data, they must create their own metadata table, upload their raw data, and change the file names listed in these sections. If the users want to add new cell or tissue types, or to create a CellNet platform for a different species, then Steps 13-21 should be followed. The magnitude of the raw gene expression data used to train the human and mouse RNA-seq versions of CellNet precludes us from making the FASTQ files for the training steps (Steps 13-16) available for download; however, we have provided the outputs from these steps (normalized expression data) so that the user can follow the subsequent steps to reconstruct GRNs (Step 17), and train and assess CellNet (Steps 18-21).
Creation of query metadata file, Step 1. The user must create a comma-separated values (.csv) file or an R data frame that contains metadata for each query sample. The metadata must include a unique sample identifier, the file name of the raw data, and an annotation (e.g., experimental group), which can be used to group the query samples in the CellNet output. Supplementary Table 1 is the .csv version of the query metadata that we use in
Step 2. The steps here are identical to those in the Step 13 in the 'Preprocessing of training data' section, except that here the sample information corresponds to samples that the user wishes to analyze with CellNet.
Preprocessing of query data, Steps 2-6. The RNA-seq preprocessing steps convert raw reads into normalized read counts per gene. To standardize the analysis and to maximize our use of publicly available RNA-seq data, we use only one end, if the data are from paired-end-read runs, and we trim reads to a length of 40 bases. We use cutadapt 25 to trim reads, and we use the quasi-mapping algorithm Salmon 26 to estimate abundances of transcripts that are defined in a user-provided FASTA file that lists the sequences of transcripts (Equipment Setup). Salmon converts the transcriptdefining FASTA file into an index that is used to perform the quasi-mapping. We have provided Salmon indices for the mouse and human transcriptomes, plus commonly used exogenous spike-ins, reporters (e.g., enhanced GFP), and selection (e.g., ampicillin) genes. To derive a read count per gene, we sum the counts per transcript across all transcripts associated with a gene. Both the indexing and the transcript-to-gene summarization are based on Ensembl-provided sequences and gene annotations (ftp://ftp.ensembl.org/pub/release-80/gtf/).
The same process is used to preprocess the training data as is used to preprocess the query data that are to be analyzed using CellNet. To make the raw expression data comparable across read depths, we down-sample the raw quasi-mapped reads such that the total reads per sample is 100,000. Effectively, we perform the down-sampling by subtracting from the raw reads an average of the total number of reads-100,000, weighted by the per-gene read count. Next, we transform the expression by taking the natural logarithm of 1 + downsampled read count. The result of this section is a transformed expression matrix. We also tested the size factor normalization approach of DESeq 27 but found that the total count normalization yielded better GRN performance, as determined by comparison with 'gold-standard' sets of transcription factor targets (Supplementary Fig. 1 
; refs. 28-30).
Analysis of query data with CellNet, Steps 7-12. Applying CellNet to the processed query data produces three outputs ( Fig. 1) : (i) the classification score, indicating the extent to which query samples are indistinguishable in their expression profile from each of the reference C/T types; (ii) the GRN status, a metric of the extent to which a C/T-specific GRN is established in a query sample; and (iii) a list of transcription factors scored according to the probability that their expression modulation would improve the desired fate change, which is called the NIS.
Preprocessing of training data, Steps 13-16. The steps here are identical to those in the 'Preprocessing of query data' section, except that the raw data here are from samples that will be used to train a new CellNet. The result of this section is a normalized expression matrix. We provide preprocessed data that can be used as input for the next section, 'GRN reconstruction'.
One of the most arduous tasks is to define and 'harvest' sufficient raw expression data. Our approach to this task is to search public repositories of gene expression data for studies that include profiles of C/Ts of interest that are from healthy, wild-type, or perturbed but noncancerous sources. For each study, we manually create a metadata table that lists sufficient information to fetch the associated raw expression data files, which we save as a .csv file. Ultimately, we combine these metadata tables into a single comprehensive metadata R file. Supplementary Table 2 illustrates the column headers and the first several rows of the example metadata table that we provide. We do not provide FASTQ files for the training data. In Step 17 of the PROCEDURE, we assume that the user has stored the FASTQ files for the training data on the computer on which they will run the PROCEDURE. FASTQ files of studies stored on Sequence Read Archive ((SRA) and listed through GEO) can be downloaded using the SRA Toolkit software (http://www. ncbi.nlm.nih.gov/books/NBK158900/). We illustrate Steps 16-21 with mouse training data. We also provide human preprocessed training data (https://github.com/pcahan1/CellNet/).
GRN reconstruction,
Step 17. CellNet is predicated upon the assumption that knowledge of the GRNs that control C/T-specific expression will yield both accurate C/T classifiers and a means of prioritizing perturbations to improve cell fate engineering protocols. There is a vast literature on using gene expression data to reconstruct GRNs, and we refer the reader to several informative reviews 31, 32 . In the original CellNet paper, we described in detail how we used the context likelihood of relatedness algorithm to reconstruct GRNs 33 , how we used the InfoMap community detection algorithm 34 to identify subnetworks, and how we used enrichment analysis to attribute subnetworks to specific C/Ts. We have subsequently found that we can identify C/T-specific GRNs by extracting the nodes and edges of C/T-enriched genes. We have found that the classifiers that result from using C/T GRNs generated in this way (i.e., by skipping the community detection step) performed as well as those generated using the earlier method but required less time to identify; therefore, the most recent CellNet code uses this approach.
Training and assessment of CellNet, Steps 18-21. This section describes the steps that ultimately result in a CellNet object that can be used to analyze query expression data. The first part of this section is dedicated to assessing the performance of the C/T classifier when CellNet is trained with a subset of the complete training data set and evaluated on the remaining, independent, and heldout part of the training data set, resulting in one precision recall curve per C/T. This section is completed by first training CellNet on the entire training data set, and then computing normalization factors on C/T GRN status metrics that will be used to scale the C/T GRN status of query samples. The result of this section is an R object that we refer to as 'cnProc'.
MaterIals
EQUIPMENT Hardware AMI, publicly available: CellNet ami-62065e75  crItIcal Preprocessing of RNA-seq training data and reconstruction of GRNs was performed on Amazon's EC2 cloud using c3.4xlarge or c3.8xlarge, or, in the case of the human data, hs1.8xlarge instance types.  crItIcal In addition to training and assessing CellNet, and analyzing query data on AWS EC2, we have also performed the PROCEDURE on a Mac OS X (version 10.9.5), and it should also be possible to complete it using most modern incarnations of Unix-like operating systems.  crItIcal Our AMI has all software needed to run the PROCEDURE, but users must fetch the transcriptome index and annotations that we provide, and install the latest version of CellNet. Software R (http://www.r-project.org/), version >=3.2.2 (Optional) Software such as Microsoft Excel (commercially available from https://products.office.com), OpenOffice (http://www.openoffice.org/ download/), or Google Docs (https://www.google.com/docs/about/) for editing metadata tables CellNet, available from GitHub as an R package: https://github.com/ pcahan1/CellNet Salmon (http://salmon.readthedocs.io/en/latest/), including the Salmon transcriptome index file, and table that relates transcripts to canonical genes, which should be downloaded as described in Step 3 of the PROCEDURE cutadapt (https://cutadapt.readthedocs.io/en/stable/)
EQUIPMENT SETUP AWS EC2 image use
The AWS EC2 image that we provide has all the necessary software installed. To use AWS, you must first create an account at https://console. aws.amazon.com/. See Box 1 for a brief introduction to AWS. You can also run the protocol on your own computer or compute cluster. The software installation and setup instructions below are necessary only if you are not running the analysis on the AWS EC2 image that we provide. Box 2 describes the modifications to Steps 2, 3, and 6 that are required to run the PROCEDURE locally. R software installation Download and install the latest version of R from http://cran.r-project.org/. Salmon installation Download and install the latest version of Salmon from https://github.com/COMBINE-lab/salmon/releases. We use version 0.6.0 on our AWS image. Refer to the Salmon documentation to resolve installation issues (http://salmon.readthedocs.io/en/latest/). If you are using MacOS 10.12 or higher, you can use this version of Salmon: https://github.com/COMBINE-lab/salmon/files/665033/Salmon-0.7.3-pre_OSX_10.12.tar.gz. Cutadapt installation Cutadapt is a Python program that can be downloaded and installed on MacOS using PIP. For example: pip install --user --upgrade cutadapt The path to cutadapt needs to be added to the $PATH environment variable. GNU parallel installation Use Homebrew to install GNU parallel. For example:
brew install parallel
Box 1 | Amazon Web Services
Amazon Web Services (AWS) is a suite of cloud-based resources that includes data storage (using S3) and computation (using EC2). AWS provides access to high-performance computing resources without the overhead of setting up and maintaining computer clusters locally. One of the main benefits is that you can configure virtual computers, termed images or Amazon machine images (AMIs), to have specific software and libraries preinstalled, which makes standardized and reproducible analysis feasible. We have configured an EC2 image so that this PROCEDURE can be reproduced by you. To access the image, you need to sign up for AWS at https://aws.amazon.com/console/. Instructions for getting started with AWS can be found at http://docs.aws.amazon.com/ AWSEC2/latest/UserGuide/get-set-up-for-amazon-ec2.html. These instructions include the creation of a key pair file required to launch and securely access an instance. We refer to this key pair file as the AWS key throughout the PROCEDURE. AWS charges users based on increments of services used. For example, the c4.8xlarge instance currently costs $1.591 per hour. Once you have launched an instance, you will be able to log in to it using ssh and your key pair. Similarly, you will use scp with your key pair to push files to, and fetch files from, your instance. CellNet installation The CellNet package should be installed by executing the following R commands: install.packages("devtools") library("devtools") install_github("pcahan1/CellNet", ref="rpackage") Input file formats There are three main file types used as input. First, there are .csv files, which can be viewed and edited using text or spreadsheet editors. Second, there are raw gene expression data (FASTQ) files of RNA-seq data, which can be viewed with text editors and are preprocessed in this PROCEDURE using a combination of Salmon and custom R scripts. Third, there are R data files (.rda files), which can be accessed only from within R.
Downloading of example data and accessory files
The magnitude of the raw gene expression data used to train the RNA-seq version of CellNet precludes us from making the FASTQ files for the training steps available for download. However, these files are available freely from the Gene Expression Omnibus (GEO) and SRA (http://www.ncbi.nlm.nih.gov/ geo/), and the user can use the SRA accession identifiers listed under the 'sra_id' column in the file sampTab_RS_mm_Oct_21_2016.rda for mouse to fetch the raw data files (see below). Anticipating that some users will want to test out the protocol without the burden of fetching raw data from GEO, we provide raw expression data that can be fetched and loaded directly into the R session starting at Step 2 and as described throughout the PROCEDURE. proceDure preparation of query sample table • tIMInG several minutes 1| Use a spreadsheet editor to create a .csv file to describe annotation information for the query data to be analyzed. supplementary table 1 illustrates how metadata should be formatted. This step is not necessary if you are following our example analysis.
preprocessing of query data • tIMInG 20 min 2| Getting started (see Box 1 for background information on AWS and Box 2 for a description of how to perform Steps 2, 3, and 6 locally). Log in to the AWS console (https://console.aws.amazon.com). Search for the CellNet AMI by clicking through 'Images'> 'AMIs', and then entering 'CellNet' into the search field for public images. Launch the image CellNet using either a c3.4xlarge or a c3.8xlarge instance type. After the instance has been launched and has completed initialization, launch a terminal, and a secure shell into the instance by typing the following command:
ssh -i aws_private_key ec2-user@instance_public_dns
Replace aws_private_key with the full path of the AWS key that you used to launch the instance. Replace instance_public_dns with the public DNS of your instance that can be found in the AWS console. fname<-'grnstats_esc_subset_SRP043684.pdf' bOrder<-c("esc_train", unique(as.vector(stQuery$description2)), "neuron_train") cn_barplot_grnSing(cnRes1,cnProc,"esc", c("esc", "neuron"), bOrder, sidCol="sra_id", dlevel="description2") ggplot2::ggsave(fname, width=5.5, height=5)
dev.off() fname<-'grnstats_neuron_subset_SRP043684.pdf' bOrder<-c("esc_train", unique(as.vector(stQuery$description2)), "neuron_train") cn_barplot_grnSing(cnRes1,cnProc,"neuron", c("esc", "neuron"), bOrder, sidCol= "sra_id", dlevel='description2') table by repeating Step 1, except that the sample information should correspond to samples that the user wishes to use to train a new CellNet object. We provide a query metadata table that the user can download (Step 16).
14| Repeat
Step 2 to set up the EC2 instance.
15| Fetch and load the metadata:
download.file("https://s3.amazonaws.com/CellNet/rna_seq/mouse/sampTab_RS_mm_Oct_21_ 2016.rda", "sampTab_RS_mm_Oct_21_2016.rda") stAll<-utils_loadObject("sampTab_RS_mm_Oct_21_2016.rda") 16| Fetch, decompress, and load the preprocessed training data, using the following command as illustrated for mouse training data: download.file("https://s3.amazonaws.com/CellNet/rna_seq/mouse/expNormTrain_RS_MM_Oct_ 21_2016.rda", "expNormTrain_RS_MM_Oct_21_2016.rda") expAll<-utils_loadObject("expNormTrain_RS_MM_Oct_21_2016.rda")  crItIcal step You will need to modify this step if you want use your own data to train a new CellNet. First, you will need to upload FASTQ files to the instance, which can be achieved using scp. Second, you will need to estimate gene expression levels as in Step 6 using the cn_salmon function, but substituting the query metadata with the training data set metadata. We recommend applying cn_salmon to subsets (rows) of the training data table distributed across several nodes. An example with a description of how to interpret precision recall curves is presented in Figure 6 . ? trouBlesHootInG Pou5f1  MYT1L  SNCA  HLF  TERF2IP  CAMTA1  DMRTC1B  CHD5  TBR1  TSPYL2  SCRT1  DDN  SOX10  SOHLH1  ZSCAN18  NEUROD2   Trim28  Sox2  Tet1  Parp1  Zfp42  Nanog  Ash2I  Kdm5b  Jarid2  Mybl2  Lin28a  Esrrb  Sall4  Rest   - Figure 6 | Precision recall curves for each murine RNA-seq C/T classifier. The x axis is the sensitivity, or the proportion of samples that are from the given C/T and are classified as such. Recall is equivalent to sensitivity. The y axis is the precision, defined as the proportion of samples classified as the given C/T that are truly derived from that C/T. Each point represents the precision versus sensitivity at a given classification score threshold. As the threshold is increased, the recall tends to decrease as the precision increases.
19|
Generate the CellNet object and save it for future use:
cnProc<-cn_make_processor(expAll, stAll, grnProp, sidCol='sra_id') fname<-paste0("cnProc_MM_RS_", mydate, ".rda") save(cnProc, file=fname) 20| Examine the expression of selected genes. Sometimes it may be useful to get an idea of the expression levels of a particular gene in each of the cell/tissue types of the training data. Running the following code will produce a 'rainbow' scatter plot that displays the expression levels of a specified gene in groups by C/T: library(ggplot2) mp_rainbowPlot(cnProc$expTrain, cnProc$stTrain, "Nkx2-5" , "description1") ggsave(file=paste("rainbowPlot_Nkx2-5_",mydate,".pdf", sep="), width=4, height=3.5) mp_rainbowPlot(cnProc$expTrain, cnProc$stTrain, "Sox2", "description1") ggsave(file=paste("rainbowPlot_Sox2_",mydate,".pdf",sep="),width=4, height=3.5) Figure 7 provides example rainbow plots.
21| Fetch the results. There are several ways to fetch the resulting files from the cloud. Below are the commands to fetch the CellNet analysis object and figures using scp. Replace aws_private_key with the AWS key you used to launch the instance, and public_dns with the instance's public name, which can be found in the AWS console:
scp -i aws_private_key -r ec2-user@instance_public_dns:/media/ephemeral0/analysis/*. pdf ./ scp -i aws_private_key ec2-user@instance_public_dns:/media/ephemeral0/analysis/*.rda ./ ? trouBlesHootInG Troubleshooting advice can be found in table 1. 
